Carcinoma in situ of skin of upper limb, including shoulder
ICD-10 D04.6 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of upper limb, including shoulder.
Carcinoma in situ of the skin of the upper limb, including the shoulder, refers to a localized form of skin cancer where abnormal cells are present in the outer layer of the skin (epidermis) but have not invaded deeper tissues. This condition is often characterized by the presence of atypical keratinocytes, which can arise from various skin lesions, including actinic keratosis or squamous cell carcinoma. Patients may present with lesions that appear as scaly patches, non-healing sores, or elevated growths. The risk factors for developing carcinoma in situ include prolonged sun exposure, fair skin, and a history of skin cancer. Early detection and treatment are crucial to prevent progression to invasive cancer. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy. Regular follow-up and skin examinations are essential for monitoring potential recurrence or new lesions.
Detailed descriptions of the lesion, including size, location, and histological findings.
Diagnosis and treatment of skin lesions, follow-up for skin cancer surveillance.
Ensure accurate coding based on biopsy results and treatment plans.
Comprehensive treatment plans, including surgical notes and follow-up care.
Management of skin cancer patients, including chemotherapy and radiation therapy.
Coordination of care with dermatology for comprehensive patient management.
Used when a biopsy is performed to confirm carcinoma in situ.
Pathology report confirming diagnosis and details of the procedure.
Dermatology and oncology must ensure accurate coding based on biopsy results.
Carcinoma in situ refers to cancer cells that are localized and have not invaded surrounding tissues, while invasive carcinoma has spread beyond the original site into deeper layers of skin or other tissues.
